Risk factor analysis of low on-treatment platelet reactivity (LTPR).
收藏数据链接：
官方服务：
资源简介：
Risk factor analysis of low on-treatment platelet reactivity (LTPR).
应用场景：
创建时间：
2023-06-23
相关数据集
Supplementary Material for: Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
Background: Individuals with transient ischemic attack and ischemic stroke have a high risk of recurrent stroke and death. While acetylsalicylic acid (ASA, aspirin) is proven and accepted as st
DataCite Commons2020-09-02 更新130
Supplementary Material for: Thromboelastography-guided antiplatelet therapy for patients with ischemic cerebrocardiovascular diseases: a systematic review and meta-analysis
Background: The effectiveness of thromboelastography (TEG)-guided antiplatelet therapy in patients with ischemic cerebrocardiovascular diseases is not well-established. This systematic review evaluate
DataCite Commons2024-06-25 更新70
Data_Sheet_1_Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke.PDF
PurposeTo identify the most important factors affecting physician decision-making regarding antiplatelet therapy. MethodsWe retrospectively gathered data from minor ischemic stroke patients with NIHSS
NIAID Data Ecosystem40
Supplementary Material for: Evaluating the Safety of Stent-Assisted Endovascular Treatment for Unruptured Cerebral Aneurysms in Older Adults: Emphasizing the Role of Antiplatelet Therapy
Introduction: This study aimed to compare the outcomes and safety in patients aged ≥75 years and those aged <75 years who underwent stent-assisted endovascular treatment for unruptured cerebral ane
DataCite Commons2024-10-10 更新90
Baseline characteristics.
Background Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resultin
NIAID Data Ecosystem60
